AI & Low-Code: The Future of Biotech IT Leadership with Kevin Dushney
Nothing about biotech IT stays static, and nothing moves faster than the expectations placed on small teams. In an industry packed with acronyms, compliance, and urgency, there’s one shift that’s rewriting the rules: AI.
In this episode, I’m joined by Kevin Dushney, a veteran CIO who’s helped shape the tech landscape across eight biotech companies. Kevin shares his perspective on building IT from scratch, getting companies launch-ready, and why small companies can now punch way above their weight. We get into the rise of AI and low-code tools, what they’re actually useful for (and what they’re not), and how fractional leadership is creating new ways to build smarter.
Kevin keeps it real, and this episode is packed with practical insights for biotech IT leaders at any stage. Tune in and hear what’s actually happening behind the scenes, then hit follow so you don’t miss what’s next.
Specifically, this episode highlights the following themes:
- How AI and low-code tools are reshaping workflows in small biotechs
- Why fractional CIOs are in demand—and how it benefits both sides
- The difference between hype and actual productivity gains with AI
Links from this episode:
- Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
- Get to know more about Kevin Dushney: https://www.linkedin.com/in/kevindushney
==== Time Stamps ====
00:00 – Introduction
01:12 – About Kevin Dushney
03:50 – Building infrastructure from scratch: what it really takes
06:52 – What AI is actually enabling in small biotechs
08:50 – Is AI reducing headcount? The real story
10:56 – Why fractional CIOs are on the rise
15:30 – Advice for new biotech IT leaders
20:55 – Low-code tools and workflow automation trends
27:09 – Getting executives up to speed on AI
32:28 – Why data governance still makes or breaks AI efforts
36:45 – Final thoughts on what’s next for biotech IT
